There are no approved medications for methamphetamine use disorder, but phase 3 trial results suggest the generic ...
Methamphetamine (MA) use disorder poses a significant public health challenge, particularly given the rise in MA-involved overdoses over the past decade. Despite the severity of this issue, there is ...
JUPITER, Fla., April 28, 2025 /PRNewswire/ -- Myosin Therapeutics, Inc., a biotechnology company developing innovative therapies for cancer and neurological disorders, today announced that it has been ...
Methamphetamine use , methamphetamine-related overdoses, and methamphetamine use disorder (MUD) are national problems that cause serious illness and death.. Making matters worse, methamphetamine is ...
Hosted on MSN
Antidepressant reduces meth addiction in trial
Use of the antidepressant mirtazapine in routine clinical practice reduced methamphetamine use in adults with methamphetamine use disorder, a phase III randomized trial showed. In participants who ...
Associate professor of forensic toxicology Heather Barkholtz and associate professor of clinical health sciences David Leinweber are leading groundbreaking research at the University of Wisconsin ...
Carrum Health launched a substance use disorder treatment program for employers a year ago and has now expanded it to include cannabis, cocaine and methamphetamine as employer demand surges. This ...
About The Study: In this parallel-group randomized clinical trial, the generic tetracyclic antidepressant mirtazapine delivered in routine clinical practice reduced methamphetamine use in adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results